ALPELISIB for Chemotherapy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where ALPELISIB was used for Chemotherapy.
Most Reported Side Effects for ALPELISIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hyperglycaemia | 1,575 | 18.7% | 94 | 415 |
| Rash | 1,393 | 16.6% | 43 | 234 |
| Diarrhoea | 1,336 | 15.9% | 55 | 267 |
| Blood glucose increased | 1,105 | 13.1% | 38 | 261 |
| Death | 921 | 10.9% | 919 | 63 |
| Nausea | 860 | 10.2% | 38 | 177 |
| Fatigue | 817 | 9.7% | 33 | 136 |
| Decreased appetite | 546 | 6.5% | 28 | 102 |
| Weight decreased | 508 | 6.0% | 22 | 92 |
| Malignant neoplasm progression | 497 | 5.9% | 136 | 99 |
| Vomiting | 479 | 5.7% | 35 | 164 |
| Asthenia | 344 | 4.1% | 34 | 110 |
| Stomatitis | 343 | 4.1% | 9 | 55 |
| Drug ineffective | 324 | 3.9% | 43 | 43 |
| Pyrexia | 272 | 3.2% | 13 | 118 |
Other Indications for ALPELISIB
Product used for unknown indication (3,166)
Breast cancer (1,914)
Breast cancer metastatic (1,372)
Breast cancer female (476)
Pik3ca related overgrowth spectrum (229)
Hormone receptor positive her2 negative breast cancer (171)
Pik3ca-activated mutation (150)
Neoplasm malignant (102)
Ovarian cancer (54)
Metastases to bone (43)
Other Drugs Used for Chemotherapy
CYCLOPHOSPHAMIDE (3,372)
DOCETAXEL (2,134)
CARBOPLATIN (1,902)
DOXORUBICIN (1,756)
VINCRISTINE (1,743)
PACLITAXEL (1,425)
OXALIPLATIN (1,423)
METHOTREXATE (1,380)
CYTARABINE (1,355)
ETOPOSIDE (1,246)